CCR7 expression is significantly increased in patients with pancreatic cancer and induces intra-tumor angiogenesis and lymphangiogenesis through chemotactic interactions with its ligand, CCL21 (Zhao et al., 2011). This evidence concerns the gene CCL21 and familial pancreatic carcinoma.